Entries |
Document | Title | Date |
20080214660 | Compounds and Methods for the Inhibition of the Expression of VCAM-1 - This invention is in the area of methods and compositions for the inhibition of the expression of VCAM-1 and, in particular, for the treatment of diseases mediated by VCAM-1, including cardiovascular and inflammatory diseases. | 09-04-2008 |
20080221205 | FURAN DERIVATIVES FOR PREVENTING AND CURING OSTEOPOROSIS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME - The present invention relates to furan derivatives and pharmaceutical compositions containing them to prevent and cure osteoporosis. The furan derivatives of the present invention have effect on bone proliferation with the side effect reduced, so that they can be used for bone disease. | 09-11-2008 |
20090093538 | Method for treating cancer - The invention relates to a method of treating cancer in a subject, comprising administering to the subject an anti-cancer therapy and a compound that increases the oxidative stress of the cancer cells and activates p38. | 04-09-2009 |
20090111870 | Angelicae Sinensis Extracts Useful for Treatment of Cancers - An acetone extract, chloroform extract or hexane extract of | 04-30-2009 |
20090149531 | CHEMICAL COMPOSITION DERIVED FROM P-HYDROXYPHENYL PROPIONIC ACID FOR THE TREATMENT OF PSORIASIS - The present invention is a chemical composition including: | 06-11-2009 |
20090247624 | FORMULATIONS OF RADIOPROTECTIVE ALPHA BETA UNSATURATED ARYL SULFONES - Solution and suspension formulations are provided for administration prior to or after exposure to ionizing radiation for reducing toxic effects of the radiation in a subject which comprises an effective amount of at least one radioprotective α,β unsaturated aryl sulfone wherein the composition has a pH within the range of about 8 to about 9. | 10-01-2009 |
20090286871 | Use of a plant oil product as an agent for increasing the synthesis of skin lipids - The present invention relates to the use of a plant oil product as an agent for increasing the synthesis of skin lipids, especially the lipids of the epidermal skin barrier, in or for the preparation of a cosmetic, pharmaceutical or dermatological composition. The invention also relates to a method for cosmetic treatment with a cosmetic, pharmaceutical or dermatological composition for increasing the synthesis of skin lipids, especially the lipids of the epidermal skin barrier, and to the use of the plant product as a food additive. | 11-19-2009 |
20100273872 | USE OF 4-OXOBUTANOIC ACID DERIVATIVES IN THE TREATMENT OF PATHOLOGIES ASSOCIATED WITH IMMUNOLOGICAL DISORDERS - The present invention relates to the use of a 4-oxobutanoic acid derivative for the preparation of a pharmaceutical composition for the treatment of pathologies associated with immunological disorders. | 10-28-2010 |
20110065785 | Non-sterile fermentation of bioethanol. - A range of concentrations exists in which fermentation inhibitors derived from pretreatment of lignocellulosic feed stocks inhibit growth of lactic acid bacteria without affecting fermentive yeast. By optimizing levels of fermentation inhibitors to fall within this range, yeast fermentations of lignocellulosic biomass can be conducted under non-sterile conditions with ethanol yields comparable to those achieved under sterile conditions. Optimised inhibitor levels can be achieved by controlling the water/biomass ratio of a lignocellulosic biomass during and after pretreatment, for example by washing the fiber fraction of a previously pretreated lignocellulosic biomass with a pre-defined amount of fresh water or recycled process solutions. Crude extracts of liquid fraction or process solutions from pretreatment of lignocellulosic biomass can also provide an effective anti-bacterial treatment for first generation starch fermentations. | 03-17-2011 |
20120041060 | TREATMENT FOR ALTITUDINAL HYPOXIA - The invention provides a method for treating hypoxia caused by high altitude by administering to a subject a compound that reduces the P | 02-16-2012 |
20120071551 | ETHANOLIC EXTRACTS OF HASS AVOCADO SEEDS, Persea americana Mill., AND ITS USE AS MITICIDE FOR Panonychus citri, Oligonychus yothersi, AND Tetranychus cinnabarinus, AND AS AN INSECTICIDE FOR Trialeurodes vaporariorum - An ethanolic extract of avocado seeds with a composition of 2-Furfuraldehyde (1,00%), 5-Methylundecane (1,05%), (11Z)-Pentadecenal (0,98%), (11Z)-Hexadecenal (2,35%), (3E)-Nonadecene (1,07%), 2-Tetradecylfuran (5,58%), 2-Pentadecylfuran (7,10%), 2-Hexadecylfuran (6,52%), 2-(1Z-Heptadecenyl) furan (2,85%), 2-(1E-Pentadecenyl) furan (2,15%), 2-(1E-Heptadecenyl) furan (5,60%), 2-(8Z, 11Z-Heptadecadienyl) furan (5,49%), 2-(8Z, 11 E-Heptadecadienyl) furan (33,53%), 2-(1 E, 8Z, 11Z-Heptadecatrienyl) furan (15,56%), and other unidentified compounds (9,17%), useful as miticide and insecticide is described. | 03-22-2012 |
20120083525 | COMPOSITION FOR PREVENTING OR TREATING OBESITY-RELATED DISEASES MEDIATED BY THE ACTIVATION OF AMPK AND INCLUDING 2,5-BIS-ARYL-3,4-DIMETHYLTETRAHYDROFURAN LIGNANS AS ACTIVE INGREDIENTS - The present invention relates to a 2,5-bis-aryl-3,4-dimethyltetrahydrofuran lignan compound which activates nutmeg-derived AMP-activated protein kinase (AMPK), and to a composition including same as active ingredients for preventing and treating metabolic syndromes such as obesity. More particularly, the present invention relates to an AMPK-activating compound comprising one of the 2,5-bis-aryl-3,4-dimethyltetrahydrofuran lignan-based compounds produced by extracting | 04-05-2012 |
20120214869 | NOVEL LIGAND ACTIVATORS OF THE RAR RECEPTORS AND PHARMACEUTICAL/COSMETIC APPLICATIONS THEREOF - Novel ligand compounds having the structural formula (I): | 08-23-2012 |
20130018092 | TREATMENT FOR HYPOXIA - The invention provides a method for treating hypoxia in a normal subject, comprising administering 5-HMF to the subject. | 01-17-2013 |
20130035383 | LIQUID/LIQUID EXTRACTION - The invention relates to a method for the extraction of all unsaponifiable fraction contained in a vegetable oil, an oil originating from a micro-organism or a vegetable butter or in a co-product from the vegetable oil refining industry, such as deodorisation discharge. The method includes at least: A) a step comprising the transformation of the aforementioned oils, butter or co-product from the vegetable oil refining industry or oils originating from micro-organisms into a hydro-alcoholic solution by means of, in particular, a step selected from saponification and esterification steps; B) a step comprising the extraction of the hydro-alcoholic solution in which the fatty fraction is separated from the unsaponitiable fraction by means of liquid/liquid extraction; and C) an optional step comprising the purification of the unsaponiable fraction, selected from the group containing crystallisation and liquid/liquid extraction steps. According to the invention, at least one step from the liquid/liquid extraction steps in step B, the crystallisation steps in step C and the liquid/liquid extraction steps in step C is performed using a first solvent system containing a concentration of solvent selected from among: fluorinated aromatic solvents, particularly trifluorotoluene (BTF) and hexalluorobenzene (BHF); tert-butyl ethers, particularly 2-ethoxy-2-methylpropane, also known as ethyl-tert-butyl-ether (ETU); solvents comprising at least one silicon atom, particularly hexamethyldisiloxane (HMDS) and tertramethylsilane (TMS); methyl-tetrahydrofuran (MeTHF); and mixtures thereof, representing at least 50 vol.-% in relation to the total volume of the solvent system. The invention also relates to the fractions obtained using this method and to compositions containing said fractions. | 02-07-2013 |
20130053437 | ANTI-INFLAMMATORY COMPOUNDS - New clerodane compounds isolated from plant material from | 02-28-2013 |
20130053438 | PHARMACEUTICAL COMPOSITIONS COMPRISING LIGNANS AND THEIR DERIVATIVES FOR THE MEDICAL MANAGEMENT OF ANGIOGENESIS AND HYPOVASCULARITY - The present invention relates to a pharmaceutical composition for stimulating angiogenesis and/or the treatment or prevention of hypovascularity and/or the prevention and/or treatment of an angiogenic disorder/disease, whereby the composition comprises specific compounds which may be obtained from | 02-28-2013 |
20140323562 | THIOSULFINATE ANTIOXIDANTS AND METHODS OF USE THEREOF - The present application provides compound of Formula X | 10-30-2014 |
20140371306 | PHARMACEUTICAL COMPOSITIONS COMPRISING LIGNANS AND THEIR DERIVATIVES FOR TREATING HYPERPLASTIC DISEASES - The present invention relates to a pharmaceutical composition comprising specific compounds which may be obtained from | 12-18-2014 |
20150011620 | ANTI-INVASIVE COMPOUNDS - The present invention relates to the field of anti-invasive compounds and methods for predicting the anti-invasive activity of said compounds, as well as their use in the prevention and/or treatment of diseases associated with undesired cell invasion; in particular, this invention relates to the field of anti-invasive chalcone-like compounds. | 01-08-2015 |
20160175274 | TREATING AN ATYPICAL PROTEIN KINASE C ENZYME ABNORMALITY | 06-23-2016 |
20220132839 | MOSQUITO ATTRACTANT COMPOSITIONS - Mosquito attractant composition for attracting a mosquito to a pre-determined location. The composition includes a combination of nonanal and lilac aldehydes. | 05-05-2022 |